UnitedHealth’s Optum involved in $2.2B physician staffing acquisition

The rapid expansion of UnitedHealth Group’s Optum division into patient care has continued, with Moody’s Investors Service identifying it as one of the acquiring firms of a physician staffing firm in Tacoma, Washington.

The sale of Sound Inpatient Physicians was already public knowledge—majority owner Fresenius Medical Care had announced in April it was divesting its stake in the company to an investment consortium led by Summit Partners.

 

No mention was made of Optum in announcing the sale. According to the Minneapolis Star-Tribune, the Moody’s report outed the UnitedHealth subsidiary as Summit’s partner in the deal when assigning a rating on debt related to the acquisition.

Sound Inpatient Physicians is ““primarily focused on providing hospital medicine,” Moody’s said in its report. “It also provides services across the acute episode of care including that for emergency rooms and critical care units. As of 2017, the company had 3,500 employees and roughly $1.3 billion in pro forma revenues.”

UnitedHealth Group hasn’t mentioned the purchase, but it falls in line with its recent acquisitions activity. In 2017, Optum’s major purchases including paying $4.9 billion for DaVita Medical Group, $2.3 billion for Surgical Care Affiliates and $1.3 billion for the Advisory Board Company’s healthcare division.

Optum’s moves come as other health insurance giants have been seeking horizontal combinations, like the proposed acquisition of Aetna by CVS Health and the merger between Cigna and Express Scripts. Unlike those more recent moves, however, Optum has been scooping physician practices for nearly a decade and now commands a physician workforce beyond that of healthcare giants like HCA.

“This is obviously scaring the crap out of hospitals in many markets,” Chas Roades, CEO of consulting firm Gist Healthcare, told Bloomberg in April.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.